Andreas Halvorsen: portfolio of Viking Global Investors
Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.
Source: 13F filing with the US Securities and Exchange Commission dated Aug 14, 2023. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q2 2023. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 24.3B USD
- Positions
- 85
- Share of the ten largest
- 37.4%
The ten largest positions Q2 2023
- Visa Inc. 7.0%▲ +8.8%
- Danaher Corporation 4.2%new
- Api Group Corp 3.8%▲ +0.3%
- Philip Morris International 3.6%new
- UnitedHealth Group 3.5%▼ −14.6%
- GE Aerospace 3.2%▼ −17.1%
- Roivant Sciences Ltd 3.1%▼ −14.7%
- Meta Platforms 3.1%▼ −19.7%
- Fortive 3.0%▲ +54.4%
- Workday, Inc. 2.8%▲ +373.0%
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q2 2023
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| UNH UnitedHealth Group | 3.5% | 1,794,275 | 862.4M USD | −14.6% reduced | Q3 2022 4 quarters |
| GE GE Aerospace | 3.2% | 7,138,176 | 784.1M USD | −17.1% reduced | Q4 2020 11 quarters |
| Roivant Sciences Ltd | 3.1% | 75,238,700 | 758.4M USD | −14.7% reduced | Q4 2021 7 quarters |
| META Meta Platforms | 3.1% | 2,594,548 | 744.6M USD | −19.7% reduced | Q4 2020 11 quarters |
| ELV Elevance Health | 2.6% | 1,412,701 | 627.6M USD | −34.4% reduced | Q1 2022 6 quarters |
| FTNT Fortinet | 2.4% | 7,689,287 | 581.2M USD | −35.3% reduced | Q4 2022 3 quarters |
| AMZN Amazon | 2.4% | 4,401,313 | 573.8M USD | −42.3% reduced | Q2 2015 33 quarters |
| INTU Intuit | 2.0% | 1,053,352 | 482.6M USD | −13.7% reduced | Q2 2022 5 quarters |
| LULU Lululemon Athletica | 1.8% | 1,189,594 | 450.3M USD | −37.2% reduced | Q1 2023 2 quarters |
| CSX CSX Corporation | 1.8% | 12,806,951 | 436.7M USD | −41.9% reduced | Q4 2022 3 quarters |
| TMO Thermo Fisher Scientific | 1.8% | 833,233 | 434.7M USD | −2.8% reduced | Q2 2020 13 quarters |
| Royalty Pharma PLC | 1.2% | 9,850,932 | 302.8M USD | −12.1% reduced | Q2 2020 13 quarters |
| Acadia Healthcare Company In | 1.1% | 3,240,894 | 258.1M USD | −3.4% reduced | Q4 2020 11 quarters |
| MCK McKesson Corporation | 0.9% | 524,143 | 224.0M USD | −83.7% reduced | Q2 2022 5 quarters |
| Karuna Therapeutics Inc | 0.8% | 947,955 | 205.6M USD | −36.8% reduced | Q3 2020 12 quarters |
| Seagate Technology Hldngs Pl | 0.8% | 3,186,400 | 197.1M USD | −42.2% reduced | Q4 2022 3 quarters |
| CB Chubb Limited | 0.8% | 970,942 | 187.0M USD | −72.0% reduced | Q1 2020 14 quarters |
| EMR Emerson Electric | 0.7% | 1,901,470 | 171.9M USD | −20.8% reduced | Q1 2023 2 quarters |
| CEG Constellation Energy | 0.4% | 1,041,072 | 95.3M USD | −49.2% reduced | Q1 2023 2 quarters |
| Rogers Comms B | 0.3% | 1,764,200 | 80.5M USD | −68.2% reduced | Q3 2022 4 quarters |
| Kbr Inc | 0.3% | 1,203,207 | 78.3M USD | −28.4% reduced | Q4 2022 3 quarters |
| Alkermes PLC | 0.3% | 2,116,275 | 66.2M USD | −23.9% reduced | Q1 2023 2 quarters |
| Guardant Health Inc | 0.2% | 1,594,326 | 57.1M USD | −37.2% reduced | Q3 2019 16 quarters |
| PGR Progressive Corporation | 0.2% | 396,437 | 52.5M USD | −60.5% reduced | Q1 2022 6 quarters |
| Zoominfo Technologies Inc | 0.1% | 1,234,538 | 31.3M USD | −81.5% reduced | Q1 2023 2 quarters |
| Farfetch Ltd | 0.1% | 4,769,602 | 28.8M USD | −32.9% reduced | Q4 2022 3 quarters |
| Pepgen Inc | < 0.1% | 1,482,434 | 13.3M USD | −4.0% reduced | Q2 2022 5 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Plus 1 position in convertible bonds and bonds worth 86.4M USD as reported – not included in the weights.
Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.
- Guardant Health Inc principal 120.0M USD 86.4M USD
Breakdown by sector
- Technology 14.8%
- Health Care 13.0%
- Financials 12.6%
- Industrials 9.4%
- Consumer Discretionary 5.4%
- Consumer Staples 4.4%
- Communication Services 4.2%
- Materials 4.2%
- Real Estate 1.5%
- Utilities 0.4%
- not in our coverage 30.1%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors